Bausch Health Companies Inc (BHC) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $5.67 (+0.35%), Market cap $2.05B, 52-week low–high $4.45 ~ $8.34.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was f
Financial statements, price targets, institutional (13F) holdings and related news for Bausch Health Companies Inc are updated in real time on BlackAll Trade.
Bausch Health Companies Inc trades at $5.67 (+0.35%). Real-time quotes and charts are available on BlackAll Trade.
Bausch Health Companies Inc has a market cap of about $2.05B.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bau